| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/09/2013 | CN102863426A Improved method for preparing (-)-pantoprazole sodium through Sharpless asymmetric epoxidation reaction |
| 01/09/2013 | CN102863425A One-step synthetic method of thalidomide and derivative thereof |
| 01/09/2013 | CN102863424A Synthetic method of medicine for treating leprosy |
| 01/09/2013 | CN102863423A Method for preparing isoquinolyl substituted pyrimidine derivative |
| 01/09/2013 | CN102863380A Preparation method of 1-alkynyl-2-aryl-1,2,3,4-tetrahydroisoquinoline compound |
| 01/09/2013 | CN102552178B Lyophilized powder injection of rabeprazole sodium medicinal composition and preparation method of lyophilized powder injection |
| 01/09/2013 | CN102153508B 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone and application of the 3,5-(E)-dibenzylidene-N-cyclopropyl piperidine-4-ketone in preparing antitumour drugs |
| 01/09/2013 | CN102093286B Acrylic acid endothelin receptor antagonist as well as preparation method and application thereof |
| 01/09/2013 | CN102060753B Refining method of 4-phenylaminopiperidine analgesic |
| 01/09/2013 | CN101798298B Imidazole derivatives |
| 01/09/2013 | CN101400655B Quinolone derivative or pharmaceutically acceptable salt thereof |
| 01/09/2013 | CN101228151B Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidine-2-ylamino)-benzamide |
| 01/09/2013 | CN101223158B N-dihydroxyalkyl-substituted 2-oxo-imidazole derivatives |
| 01/09/2013 | CN101146791B 4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamid acid addition salts as kinase inhibitors |
| 01/08/2013 | US8350055 Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
| 01/08/2013 | US8350045 Process for preparation of E-isomer of 1-(4-methylphenyl)-1-(2-pyridyl)-3-pyrrolidino prop-1-ene and acid addition salts thereof |
| 01/08/2013 | US8350034 Substituted chiral fused [1,2]imidazo[4,5-C] ring compounds |
| 01/08/2013 | US8350027 Dual-acting pyrazole antihypertensive agents |
| 01/08/2013 | US8349886 Nitrogenated 5-membered heterocyclic compound |
| 01/08/2013 | US8349874 Cyclohexane derivative and pharmaceutical use thereof |
| 01/08/2013 | US8349871 Therapeutic uses of compounds which selectively modulate the CB2 receptor |
| 01/08/2013 | US8349861 Methods for identification of JAK kinase interacting molecules and for the purification of JAK kinases |
| 01/08/2013 | US8349859 Pyrimidine derivatives |
| 01/08/2013 | US8349842 Therapeutic agents useful for treating pain |
| 01/08/2013 | US8349831 Osteoporosis, bone disorders, or diseases associated with excessive secretion of PTH, such as hyperparathyroidism; reduce or inhibit parathyroid hormone (PTH) secretion |
| 01/08/2013 | US8349830 Aryl aminopyridine PDE10 inhibitors |
| 01/08/2013 | US8349817 Analogues of cilostazol |
| 01/08/2013 | CA2677315C Pyrimidinylaminobenzamide derivatives and their use as inhibitors of tyrosine kinases |
| 01/08/2013 | CA2642668C Indole-3-carboxylic acid amide and ester compounds bearing phenyl groups having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 01/08/2013 | CA2578441C Pyrimidine sulphonamide derivatives as chemokine receptor modulators |
| 01/08/2013 | CA2562571C Novel androgens |
| 01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
| 01/03/2013 | WO2013002357A1 Hiv replication inhibitor |
| 01/03/2013 | WO2013002196A1 Novel pharmaceutical composition |
| 01/03/2013 | WO2013000943A1 Microbiocidal heterocycles |
| 01/03/2013 | WO2013000267A1 Azole heterocyclic compound, preparation method, pharmaceutical composition and use |
| 01/03/2013 | WO2013000108A1 Azole heterocylic compounds, preparation methods, pharmaceutical compositions and uses thereof |
| 01/03/2013 | WO2012150784A3 Novel indole derivative or pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic diseases containing same as active ingredient |
| 01/03/2013 | WO2012149186A3 Novel bisaminoquinoline compounds, pharmaceutical compositions prepared therefrom and their use |
| 01/03/2013 | US20130005974 Synthesis of a neurostimulative piperazine |
| 01/03/2013 | US20130005965 Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 01/03/2013 | US20130005964 Sulfonyl amide derivatives for the treatment of abnormal cell growth |
| 01/03/2013 | US20130005963 Organic photoelectric conversion material and organic thin-film photoelectric conversion device |
| 01/03/2013 | US20130005773 Fluoro-substituted 2-aryl-3,5-dicyano-4-indazolyl-6-methyl-1,4-dihydropyridines and uses thereof |
| 01/03/2013 | US20130005770 Organic compounds |
| 01/03/2013 | US20130005769 Inhibitors of the interaction between mdm2 and p53 |
| 01/03/2013 | US20130005765 Methods and Compositions for Controlling Ectoparasites |
| 01/03/2013 | US20130005759 Small molecule modifiers of microrna mir-122 |
| 01/03/2013 | US20130005755 Peripherally Acting Opioid Compounds |
| 01/03/2013 | US20130005752 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005744 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders |
| 01/03/2013 | US20130005741 Substituted pyrimidine as a prostaglandin d2 receptor antagonist |
| 01/03/2013 | US20130005736 Antiviral agents |
| 01/03/2013 | US20130005729 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005728 Substituted pyrimidines as prostaglandin d2 receptor antagonists |
| 01/03/2013 | US20130005727 Quinazoline derivatives |
| 01/03/2013 | US20130005719 Metalloenzyme inhibitor compounds |
| 01/03/2013 | US20130005716 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 01/03/2013 | US20130005710 Aminopyridine derivative |
| 01/03/2013 | US20130005709 Sulfone compounds as 5-ht6 receptor ligands |
| 01/03/2013 | US20130005705 Novel inhibitor compounds of phosphodiesterase type 10a |
| 01/03/2013 | US20130005702 Pyrazole derivatives as protein kinase modulators |
| 01/03/2013 | US20130005675 Quinolone compound and pharmaceutical composition |
| 01/03/2013 | US20130005574 3-alkoxy, thioalkyl and amino-4-amino-6-(substituted)picolinates and their use as herbicides |
| 01/03/2013 | US20130004518 Cyclic amine bace-1 inhibitors having a benzamide substituent |
| 01/03/2013 | US20130004457 Hepatitis C Virus Inhibitors |
| 01/03/2013 | US20130002526 Novel organic compound and organic light-emitting device |
| 01/03/2013 | US20130001529 Heterocyclic compound and organic light-emitting device including the same |
| 01/03/2013 | US20130001527 Heterocyclic compound, organic light-emitting diode including the heterocyclic compound, and flat display device including the organic light-emitting diode |
| 01/03/2013 | US20130001524 Heterocyclic compound and organic light-emitting device comprising the same |
| 01/03/2013 | US20130001522 Heterocyclic compound and organic light-emitting device including the same |
| 01/03/2013 | CA2840332A1 Microbiocidal heterocycles |
| 01/02/2013 | EP2541635A1 Organic electroluminescent element |
| 01/02/2013 | EP2540716A1 Tetrazolyloxime derivative or a salt thereof, and germicide |
| 01/02/2013 | EP2540715A1 Fused substituted aminopyrrolidine derivative |
| 01/02/2013 | EP2540707A1 Substituted pyridyl compound and organic electroluminescent element |
| 01/02/2013 | EP2539706A1 Arylpiperazone opioid receptor antagonists |
| 01/02/2013 | EP2539341A1 Derivatives of 1-phenyl-1,5-dihydro-benzo[b][1.4]diazepine-2.4-dione as inhibitors of hiv replication |
| 01/02/2013 | EP2539333A1 Dimeric iap inhibitors |
| 01/02/2013 | EP2539326A1 Bisaryl-bonded aryltriazolones and use thereof |
| 01/02/2013 | EP2539323A1 Compounds as bradykinin b1 antagonists |
| 01/02/2013 | EP2539322A1 Inhibitors of beta-secretase |
| 01/02/2013 | EP2538787A1 Triazolones as fatty acid synthase inhibitors |
| 01/02/2013 | CN1823041B 1,4-dihydropyridine and pyridine compounds as calcium channel blockers |
| 01/02/2013 | CN102858763A Prolylhydroxylase inhibitors and methods of use |
| 01/02/2013 | CN102858762A Novel salts for the manufacture of pharmaceutical compositions |
| 01/02/2013 | CN102858748A Therapeutic agent and preventative agent for Alzheimer's disease |
| 01/02/2013 | CN102858746A Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 01/02/2013 | CN102858744A Trypsin-like Serine Protease Inhibitors, And Their Preparation And Use |
| 01/02/2013 | CN102858743A Spiro-condensed cyclohexane derivatives as HSL inhibitors useful for the treatment of diabetes |
| 01/02/2013 | CN102858742A Trpv1 vanilloid receptor antagonists with a bicyclic portion |
| 01/02/2013 | CN102858739A A process for amidation of pyrrole carboxylate compounds |
| 01/02/2013 | CN102858340A Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
| 01/02/2013 | CN102850328A Pyridine chemical, its preparation method, and pharmaceutical composition containing the chemical and application thereof |
| 01/02/2013 | CN102850327A Intermediate for preparing Dabigatran etexilate, and preparation method and application thereof |
| 01/02/2013 | CN102850326A Dabigatran etexilate novel intermediate, and preparation method and application thereof |
| 01/02/2013 | CN102850325A Preparation method of Dabigatran etexilate key intermediate |
| 01/02/2013 | CN102850324A Indole compounds |
| 01/02/2013 | CN102850323A Refining method of esomeprazole sodium |
| 01/02/2013 | CN102850322A Heterocyclic compound, organic light-emitting device, and panel display device |